Baldwin Leads Colleagues to Urge Judge to Reject $3.5 Million Bonus for CEO of Bankrupt Purdue Pharma
Executives Involved in Wrongdoing Should Not be Paid Before Families Devastated by the Opioid Company's Actions, Senators Say
WASHINGTON, D.C. – U.S. Senator Tammy Baldwin today led her colleagues in sending a letter to Judge Robert D. Drain, urging him to reject Purdue Pharma’s proposal to pay President and CEO Craig Landau a bonus of up to $3.5 million.
Purdue’s opioid marketing campaignaccelerated an opioid epidemic that has claimed an estimated 400,000 lives. The campaign generated$35 billion in revenue for Purdue and likely significant incentive bonus compensation for Mr. Landau for achieving ambitious opioid sales targets. The Senatorsraise new concerns regarding company practices that took place during Mr. Landau’s tenure, and highlight how the company has continued to promote their opioid products, despite multiple lawsuits and thousands of personal injury claims.
The letter was led by Senator Baldwin and signed by Senators Joe Manchin (D-WV), Maggie Hassan (D-NH), Tina Smith (D-MN) and Richard Blumenthal (D-CT).
The full letter is available here.
An online version of this release is available here.
NOTE: This press release was submitted to Urban Milwaukee and was not written by an Urban Milwaukee writer. While it is believed to be reliable, Urban Milwaukee does not guarantee its accuracy or completeness.
Mentioned in This Press Release
Recent Press Releases by U.S. Sen. Tammy Baldwin
Senator Baldwin Introduces Bill to Cap Prescription Drug Costs
Feb 14th, 2025 by U.S. Sen. Tammy BaldwinThe Capping Prescription Costs Act would cap annual out-of-pocket prescription drug costs per year at $2,000 for individuals and $4,000 for families
Senator Baldwin Exposes Trump Administration Halt on Lifesaving Research, Despite Court Orders
Feb 14th, 2025 by U.S. Sen. Tammy BaldwinNEW: Baldwin reveals that NIH has awarded zero grants in 10 days and is failing to fund research projects, including to find a cure for Alzheimer’s disease